Skip to main content

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Marta Ribases Haro

Institutions of which they are part

Main researcher
Psychiatry, Mental Health and Addictions
Vall Hebron Institut de Recerca

Research lines

Psychiatric Genetics

IP: Marta Ribases Haro

Projects

Más allá del riesgo genético para el TDAH: contribución genética a la resiliencia en una muestra clínica

IP: Marta Ribases Haro
Collaborators: -
Funding agency: Instituto de Salud Carlos III
Funding: 131250
Reference: PI23/00404
Duration: 01/01/2024 - 31/12/2026

Grup consolidat

IP: José Antonio Ramos Quiroga
Collaborators: Pilar Lusilla Palacios, Natalia Calvo Piñero, Amanda Rodríguez Urrutia, Montserrat Corrales De la Cruz, Judit Cabana Dominguez, Marc Ferrer Vinardell, Gemma Nieva Rifa, Mª Dolores Braquehais Conesa, Lara Grau Lopez, Constanza Daigre Blanco, Marta Ribases Haro, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Mireia Forner Puntonet, Christian Fadeuilhe Grau, Francisco Collazos Sanchez, Silvia Alemany Sierra, Silvia Amoretti Guadall, Gara Arteaga Henriquez, Oscar Soto Angona, Natalia Llonga Tejedor, Maria Soler Artigas, Jorge Lugo Marin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00840
Duration: 01/01/2022 - 31/12/2024

Impact of Neurodevelopmental Disorders on School Performance: genes and environment (INSchool)

IP: Marta Ribases Haro
Collaborators: Gemma Español Martín, Judit Cabana Dominguez, José Antonio Ramos Quiroga, Laura Gisbert Gustemps, Vanesa Richarte Fernández, Silvia Alemany Sierra, Natalia Llonga Tejedor, Maria Soler Artigas
Funding agency: Fundació La Marató de TV3
Funding: 199187.5
Reference: 202228-30-31
Duration: 20/04/2023 - 19/04/2026

DynAMoND - Dinámica de la modulación afectiva en los trastornos del neurodesarrollo

IP: José Antonio Ramos Quiroga
Collaborators: Natalia Calvo Piñero, Montserrat Corrales De la Cruz, Marc Ferrer Vinardell, Marta Ribases Haro, Vanesa Richarte Fernández, Christian Fadeuilhe Grau
Funding agency: Instituto de Salud Carlos III
Funding: 174845
Reference: AC21_2/00048
Duration: 01/01/2022 - 31/12/2024

Related news

The new drug improves core symptoms of depression in just three days

This new method improves and streamlines drug development processes

Complemented with the analysis of genetic variants, the work led by Vall d'Hebron establishes the basis for using gene expression as a potential biomarker of risk of developing the disorder.

Related professionals

Jorge Pamias Romero

Jorge Pamias Romero

New Technologies and Craniofacial Microsurgery
Read more
Luis Enrique Lara Moctezuma

Luis Enrique Lara Moctezuma

Kidney Physiopathology
Read more
Jorge Leno Colorado

Jorge Leno Colorado

Research technician
Genetics Medicine
Read more
José Manuel Vidal Taboada

José Manuel Vidal Taboada

Main researcher
Peripheral Nervous System
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.